A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we present an integrated protocol that measures monocyte subpopulation trafficking under flow in vitro by use of specific surface markers and confocal fluorescence microscopy. This protocol can be used to explore sequential recruitment steps as well as to profile other leukocyte subtypes using other specific surface markers.
The recruitment of monocytes from the blood to targeted peripheral tissues is critical to the inflammatory process during tissue injury, tumor development and autoimmune diseases. This is facilitated through a process of capture from free flow onto the luminal surface of activated endothelial cells, followed by their adhesion and transendothelial migration (transmigration) into the underlying affected tissue. However, the mechanisms that support the preferential and context-dependent recruitment of monocyte subpopulations are still not fully understood. Therefore, we have developed a method that allows the recruitment of different monocyte subpopulations to be simultaneously visualized and measured under flow. This method, based on time-lapse confocal imaging, allows for the unambiguous distinction between adherent and transmigrated monocytes. Here, we describe how this method can be used to simultaneously study the recruitment cascade of pro-angiogenic and non-angiogenic monocytes in vitro. Furthermore, this method can be extended to study the different steps of recruitment of up to three monocyte populations.
Monocytes constitute a phagocytic component of innate immunity that is essential for fighting pathogens, cleaning up damaged tissues, angiogenesis, and the pathophysiology of many diseases including cancers1,2,3. Monocytes are bone marrow-derived cells composed of heterogeneous subpopulations that circulate in the blood but can be recruited to the site of inflammation in peripheral tissue through specific molecular mechanisms. The recruitment cascades of monocytes, as for leukocytes in general, implicates different steps including capture, rolling, crawling, arrest, transendo....
Human materials were used with the informed consent of volunteer donors and in accordance with the Swiss Ethics Committees on clinical research.
1. Isolation and Freezing of Human Umbilical Vein Endothelial Cells (HUVEC)
Determining the state of HUVEC activation induced by TNFα
The bio-activity of the inflammatory cytokine TNFα can be vary according to the batch and the repletion of freezing-thawing cycle. It is important to check the activation status of HUVEC with TNFα treatment. This could be performed by staining in parallel some samples of confluent HUVEC for the inflammatory induction of selectins, ICAM-1 and VCAM-1
Here, we report a method detailing a study of how monocyte subpopulations transmigrate through the inflamed endothelial monolayer. The discussed method used confocal microscopy instead of phase-contrast microscopy, which is also used to study monocyte recruitment under flow3,11,19. One major advantage of using confocal microscopy for time-lapse imaging is the ability to unambiguously discriminate between transmigration and stron.......
We thank Dr. Paul Bradfield for manuscript reading and feedbacks. A. S. received financial support from the Sir Jules Thorn Charitable Overseas Trust Reg.,
....Name | Company | Catalog Number | Comments |
Tissue Culture Flasks 75 cm2 | TPP | 90076 | Routine culture of isolated HUVEC |
µ-Slide VI 0.4 | IBIDI | 80606 | |
Centrifuge Tubes 15 mL | TPP | 191015 | |
Centrifuge Tubes 50 mL | TPP | 191050 | |
Collagen G | Biochrom | L 7213 | For coating of cell culture flasks |
Gelatin | Sigma-Aldrich | 1393 | For coating of cell culture flasks |
Dulbecco’s Phosphate Buffered Saline (without MgCl2 and CaCl2) | Sigma-Aldrich | D8537 | |
Dulbecco’s Phosphate Buffered Saline (with MgCl2 and CaCl2) | Sigma-Aldrich | D8662 | |
RPMI-1640 Medium | Sigma-Aldrich | R8758 | |
3-Way Stopcocks | BIO-RAD | 7328103 | |
penicillin 10000 u/ml streptomycine 10000 ug/ml fungizone 25 ug/ml | AMIMED | 4-02F00-H | |
Collagenase type 1 | Worthington | LS004216 | |
Medium 199 1X avec Earle's salts, L-Glutamine, 25 mM Hepes | GIBCO | 22340020 | |
Bovine Albumin Fraction V | ThermoFisher | 15260037 | |
Endothelial Cell Growth Supplement, 150mg | Millipore | 02-102 | |
Heparin Sodium | Sigma-Aldrich | H3149RT | |
Hydrocortisone | Sigma-Aldrich | H6909 | |
L-Ascorbic acid | Sigma-Aldrich | A 4544 | |
EDTA disodium salt dihydrate C10H14N2Na2O8 · 2H2O | APPLICHEM | A2937.0500 | |
CD144 (VE-Cadherin), human recombinant clone: REA199, FITC | Miltenyi Biotech | 130-100-713 | AB_2655150 |
CD31-PE antibody, human recombinant clone: REA730, PE | Miltenyi Biotech | 130-110-807 | AB_2657280 |
Anti-Podoplanin-APC, human recombinantclone: REA446, APC | Miltenyi Biotech | 130-107-016 | AB_2653263 |
BD Accuri C6 Plus | BD Bioscience | ||
µ-Slide I Luer | IBIDI | 80176 | |
CMFDA (5-chloromethylfluorescein diacetate) | ThermoFisher | C2925 | |
Recombinant human TNFα | Peprotech | 300-01A | |
Recombinant human VEGFA | Peprotech | 100-20 | |
NE-1000 Programmable Syringe Pump | KF Technology | NE-1000 | |
Ficoll Paque Plus | GE Healthcare | 17-1440-02 | |
Anti-human CD14-PE, human recombinant clone: REA599, PE | Miltenyi Biotech | 130-110-519 | AB_2655051 |
Pan Monocyte Isolation Kit, human | Miltenyi Biotech | 130-096-537 | |
Anti-human CD16-PE, human recombinant clone: REA423, PE | Miltenyi Biotech | 130-106-762 | AB_2655403 |
LS columns | Miltenyi Biotech | 130-042-401 | |
QuadroMACS Separator | Miltenyi Biotech | 130-090-976 | |
Hoechst 33342, Trihydrochloride, Trihydrate | ThermoFisher | H1399 | |
Silicone tubing | IBIDI | 10841 | |
Elbow Luer Connector | IBIDI | 10802 | |
Female Luer Lock Coupler | IBIDI | 10823 | |
Luer Lock Connector Female | IBIDI | 10825 | |
In-line Luer Injection Port | IBIDI | 10820 | |
Ar1 confocal microscope | Nikon | ||
40X objective | Nikon | 40x 0.6 CFI ELWD S Plane Fluor WD:3.6-2.8mm correction 0-2mm | |
ImageJ Software | NIH |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved